References
- 1. Chard T, Soe A, Costeloe K. The risk of neonatal death and respiratory distress syndrome in relation to birth weight of preterm infants. Am J Perinatol. 1997;14:523–6.
- 2. Hack M, Horbar JD, Malloy MH, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. Pediatrics 1991;87:587–97.
- 3. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med. 1971;284:1333–40.
- 4. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454.
- 5. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 1990;97:11–25.
- 6. Finer NN, Carlo WA, Walsh MC, et al. The Support Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;27:1970–9.
- 7. Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2002:CD002975.
- 8. Henderson-Smart DJ, Wilkinson A, Raynes-Greenow CH. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. Cochrane Database Syst Rev. 2002:CD002770.
- 9. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;17:CD003063.
- 10. Kamper J, Wulff K, Larsen C, Lindequist S. Early treatment with nasal continuous positive airway pressure in very lowbirthweight infants. Acta Paediatr. 1993;82:193–7.
- 11. Ammari A, Suri M, Milisavljevic V, et al. Variables associated with the early failure of nasal CPAP in very low birth weight infants. Journal of Pediatrics 2005;147:341–7.
- 12. Kattwinkel J, Perlman JM, Aziz K, et al. Part 15: neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010;122:S909–19.
- 13. Sweet DG, Carnielli V, Greisen G, et al. European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2010 update. Neonatology 2010;97:402–17.
- 14. Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2013 update. Neonatology 2013;103:353–68.
- 15. Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11:CD001456.
- 16. Koch L, Frommhold D, Beedgen B, Ruef P, Poeschl J. Prophylactic Administration of Surfactant in Extremely Premature Infants. Crit Care Res Pract. 2010;2010:235894. doi: 10.1155/2010/235894.
- 17. Victorin LH, Deverajan LV, Curstedt T, Robertson B. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease – a pilot study. Biol Neonate 1990;58:121–6.
- 18. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med. 1994;331:1051–5.
- 19. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol. 2007;27:422–7.
- 20. Dani C, Corsini I, Bertini G, et al. The INSURE method in preterm infants of less than 30 weeks’ gestation. J Matern Fetal Neonatal Med. 2010;23:1024–9.
- 21. Brix N, Sellmer A, Jensen MS, Vad Pedersen L, Henriksen TB. Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study. BMC Pediatr. 2014;14:155.
- 22. Nayeri FS, Shirvani TE, Aminnezhad M, et al. Comparison of INSURE Method with Conventional Mechanical Ventilation after Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: Therapeutic Challenge. Acta Medica Iranica 2014;52:604-8.
- 23. Ting L, Hong J, Dong-Yun L, Xiang-Hong L. Risk factors for the failure of the InSure method in very preterm infants with respiratory distress syndrome. CJCP 2014;16:610-3.
- 24. Najafian B, Saburi A, Fakhraei SH, et al. Predicting Factors of INSURE Failure in Low Birth-Weight Neonates with Respiratory Distress Syndrome: A Logistic Regression Model. IJN 2014;5:31-4
- 25. Cherif A, Hachani C, Khrouf N. Factors associated with INSURE method failure in preterm infants with respiratory distress syndrome. The Internet Journal of Pediatrics and Neonatology 2007;8:1-5.
- 26. Gharehbaghi MM, Peirovifar A, Ghojazadeh M. Risk factors contributing to the failure of surfactant administration with INSURE method. J Pioneer Med Sci. 2014;4:55-9.
- 27. Leone F, Trevisanuto D, Cavallin F, Parotto M, Zanardo V. Efficacy of INSURE during nasal CPAP in preterm infants with respiratory distress syndrome. Minerva Pediatr. 2013;65:187-92.
- 28. Stoicescu SM, Năstase L, Ciochină E, et al. Management of respiratory distress syndrome due to surfactant deficit. [Managementul sindromului de detresă respiratorie prin deficit de surfactant]. Ghiduri Clinice pentru Neonatologie. Ghidul 07. Editura Alma Mater Sibiu, Romania.
- 29. Stoicescu SM, Androne A, Dicu A, et al. Oxygen therapy in neonates [Oxigenoterapia la nou-născut]. Ghiduri Clinice pentru Neonatologie. Ghidul 08. Editura Alma Mater Sibiu, Romania.
- 30. Kirsten GF, Kirsten CL, Henning PA, et al. The outcome of ELBW infants treated with NCPAP and InSurE in a resource-limited institution. Pediatrics. 2012;129:e952-9.